{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:12:10Z","timestamp":1787343130016,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T00:00:00Z","timestamp":1226534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T00:00:00Z","timestamp":1226534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/leu.2008.323","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T10:46:47Z","timestamp":1226573207000},"page":"545-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia"],"prefix":"10.1038","volume":"23","author":[{"given":"V","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"W","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D L","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Larghero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Devergie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Skvortsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Socie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Zago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,13]]},"reference":[{"key":"BFleu2008323_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1146\/annurev.genom.2.1.9","volume":"2","author":"WE Evans","year":"2001","unstructured":"Evans WE, Johnson JA . Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet 2001; 2: 9\u201339.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BFleu2008323_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2141.2004.05216.x","volume":"127","author":"AM Dickinson","year":"2004","unstructured":"Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E . Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127: 479\u2013490.","journal-title":"Br J Haematol"},{"key":"BFleu2008323_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"348","author":"WE Evans","year":"2003","unstructured":"Evans WE, McLeod HL . Pharmacogenomics\u2014drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538\u2013549.","journal-title":"N Engl J Med"},{"key":"BFleu2008323_CR4","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V94.11.3941","volume":"94","author":"J Cavet","year":"1999","unstructured":"Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM . Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941\u20133946.","journal-title":"Blood"},{"key":"BFleu2008323_CR5","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa022060","volume":"349","author":"MT Lin","year":"2003","unstructured":"Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201\u20132210.","journal-title":"N Engl J Med"},{"key":"BFleu2008323_CR6","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2002-04-1033","volume":"100","author":"V Rocha","year":"2002","unstructured":"Rocha V, Franco RF, Porcher R, Bittencourt H, Silva Jr WA, Latouche A et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908\u20133918.","journal-title":"Blood"},{"key":"BFleu2008323_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00007890-200108270-00024","volume":"72","author":"G Socie","year":"2001","unstructured":"Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001; 72: 699\u2013706.","journal-title":"Transplantation"},{"key":"BFleu2008323_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.tpj.6500157","volume":"3","author":"HJ Xie","year":"2003","unstructured":"Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M et al. Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomics J 2003; 3: 53\u201361.","journal-title":"Pharmacogenomics J"},{"key":"BFleu2008323_CR9","first-page":"49","volume-title":"High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells","author":"RB Jones","year":"2000","unstructured":"Jones RB, Matthes S, Cagnoni P . Pharmacokinetics. In: Armitage JO, Antman KH (eds). High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells, 3rd edn, Lippincott Williams and Wilkins: Philadelphia, 2000, pp 49\u201368."},{"key":"BFleu2008323_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0006-2952(99)00321-4","volume":"59","author":"O Grenet","year":"2000","unstructured":"Grenet O, Bobadilla M, Chibout SD, Steiner S . Evidence for the impairment of the vitamin D activation pathway by cyclosporine A. Biochem Pharmacol 2000; 59: 267\u2013272.","journal-title":"Biochem Pharmacol"},{"key":"BFleu2008323_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bmt.1702852","volume":"27","author":"R Morariu-Zamfir","year":"2001","unstructured":"Morariu-Zamfir R, Rocha V, Devergie A, Socie G, Ribaud P, Esperou H . et al. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplant 2001; 27: 575\u2013580.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2008323_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2008323_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00008571-200107000-00004","volume":"11","author":"T Lang","year":"2001","unstructured":"Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 11: 399\u2013415.","journal-title":"Pharmacogenetics"},{"key":"BFleu2008323_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1006\/bbrc.2001.4524","volume":"281","author":"N Ariyoshi","year":"2001","unstructured":"Ariyoshi N, Miyazaki M, Toide K, Sawamura Y, Kamataki T . A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation. Biochem Biophys Res Commun 2001; 281: 1256\u20131260.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2008323_CR15","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1182\/blood.V98.12.3483","volume":"98","author":"KA Lee","year":"2001","unstructured":"Lee KA, Kim SH, Woo HY, Hong YJ, Cho HC . Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia. Blood 2001; 98: 3483\u20133485.","journal-title":"Blood"},{"key":"BFleu2008323_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1096\/fasebj.14.5.791","volume":"14","author":"MH Wilson","year":"2000","unstructured":"Wilson MH, Grant PJ, Hardie LJ, Wild CP . Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2000; 14: 791\u2013796.","journal-title":"FASEB J"},{"key":"BFleu2008323_CR17","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473\u20133478.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008323_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111\u2013113.","journal-title":"Nat Genet"},{"key":"BFleu2008323_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1365-2141.1999.01254.x","volume":"105","author":"RF Franco","year":"1999","unstructured":"Franco RF, Morelli V, Lourenco D, Maffei FH, Tavella MH, Piccinato CE et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 1999; 105: 556\u2013559.","journal-title":"Br J Haematol"},{"key":"BFleu2008323_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/JCO.1995.13.5.1103","volume":"13","author":"A Bedi","year":"1995","unstructured":"Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103\u20131109.","journal-title":"J Clin Oncol"},{"key":"BFleu2008323_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BFleu2008323_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFleu2008323_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","volume":"57","author":"KM Sullivan","year":"1981","unstructured":"Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267\u2013276.","journal-title":"Blood"},{"key":"BFleu2008323_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00125817-200207000-00003","volume":"4","author":"SS Coughlin","year":"2002","unstructured":"Coughlin SS, Hall IJ . Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med 2002; 4: 250\u2013257.","journal-title":"Genet Med"},{"key":"BFleu2008323_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1383-5742(99)00005-8","volume":"436","author":"M Taningher","year":"1999","unstructured":"Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S . Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 1999; 436: 227\u2013261.","journal-title":"Mutat Res"},{"key":"BFleu2008323_CR26","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/301825","volume":"62","author":"NM van der Put","year":"1998","unstructured":"van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044\u20131051.","journal-title":"Am J Hum Genet"},{"key":"BFleu2008323_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/0091270003253617","volume":"43","author":"CR Yates","year":"2003","unstructured":"Yates CR, Zhang W, Song P, Li S, Gaber AO, Kotb M et al. The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients. J Clin Pharmacol 2003; 43: 555\u2013564.","journal-title":"J Clin Pharmacol"},{"key":"BFleu2008323_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM199707103370210","volume":"337","author":"BL Riggs","year":"1997","unstructured":"Riggs BL . Vitamin D-receptor genotypes and bone density. N Engl J Med 1997; 337: 125\u2013126.","journal-title":"N Engl J Med"},{"key":"BFleu2008323_CR29","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1097\/00007632-199812010-00002","volume":"23","author":"T Videman","year":"1998","unstructured":"Videman T, Leppavuori J, Kaprio J, Battie MC, Gibbons LE, Peltonen L et al. Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine 1998; 23: 2477\u20132485.","journal-title":"Spine"},{"key":"BFleu2008323_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1902\/jop.1999.70.9.1032","volume":"70","author":"BJ Hennig","year":"1999","unstructured":"Hennig BJ, Parkhill JM, Chapple IL, Heasman PA, Taylor JJ . Association of a vitamin D receptor gene polymorphism with localized early-onset periodontal diseases. J Periodontol 1999; 70: 1032\u20131038.","journal-title":"J Periodontol"},{"key":"BFleu2008323_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1086\/314536","volume":"179","author":"S Roy","year":"1999","unstructured":"Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV . Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999; 179: 187\u2013191.","journal-title":"J Infect Dis"},{"key":"BFleu2008323_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"116","author":"RJ Gray","year":"1988","unstructured":"Gray RJ . A class K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 116: 1141\u20131154.","journal-title":"Ann Stat"},{"key":"BFleu2008323_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"BFleu2008323_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/biomet\/76.2.297","volume":"76","author":"CLIFFORD M. HURVICH","year":"1989","unstructured":"Hurvich CM . Regression and time series model selection in small samples. Biometrika, Vol. 76 1989, pp 297\u2013307.","journal-title":"Biometrika"},{"key":"BFleu2008323_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/00129785-200303060-00002","volume":"3","author":"DW Nebert","year":"2003","unstructured":"Nebert DW, Jorge-Nebert L, Vesell ES . Pharmacogenomics and \u2018individualized drug therapy\u2019: high expectations and disappointing achievements. Am J Pharmacogenomics 2003; 3: 361\u2013370.","journal-title":"Am J Pharmacogenomics"},{"key":"BFleu2008323_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0006-2952(99)00410-4","volume":"59","author":"Z Huang","year":"2000","unstructured":"Huang Z, Roy P, Waxman DJ . Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol 2000; 59: 961\u2013972.","journal-title":"Biochem Pharmacol"},{"key":"BFleu2008323_CR37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BFleu2008323_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1124\/jpet.300.2.361","volume":"300","author":"DG McCarver","year":"2002","unstructured":"McCarver DG, Hines RN . The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 2002; 300: 361\u2013366.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu2008323_CR39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","volume":"104","author":"A Srivastava","year":"2004","unstructured":"Srivastava A, Poonkuzhali B, Shaji RV, George B, Mathews V, Chandy M et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 2004; 104: 1574\u20131577.","journal-title":"Blood"},{"key":"BFleu2008323_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/1098-2744(200011)29:3<170::AID-MC6>3.0.CO;2-W","volume":"29","author":"CS Morrow","year":"2000","unstructured":"Morrow CS, Smitherman PK, Townsend AJ . Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells. Mol Carcinog 2000; 29: 170\u2013178.","journal-title":"Mol Carcinog"},{"key":"BFleu2008323_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0027-5107(01)00209-3","volume":"482","author":"M Dusinska","year":"2001","unstructured":"Dusinska M, Ficek A, Horska A, Raslova K, Petrovska H, Vallova B et al. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res 2001; 482: 47\u201355.","journal-title":"Mutat Res"},{"key":"BFleu2008323_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-2478(02)00035-4","volume":"81","author":"A Ouaissi","year":"2002","unstructured":"Ouaissi A, Ouaissi M, Sereno D . Glutathione S-transferases and related proteins from pathogenic human parasites behave as immunomodulatory factors. Immunol Lett 2002; 81: 159\u2013164.","journal-title":"Immunol Lett"},{"key":"BFleu2008323_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1182\/blood.V98.1.231","volume":"98","author":"CM Ulrich","year":"2001","unstructured":"Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J et al. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001; 98: 231\u2013234.","journal-title":"Blood"},{"key":"BFleu2008323_CR44","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/10.5.433","volume":"10","author":"Z Chen","year":"2001","unstructured":"Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10: 433\u2013443.","journal-title":"Hum Mol Genet"},{"key":"BFleu2008323_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00008571-200204000-00001","volume":"12","author":"WE Evans","year":"2002","unstructured":"Evans WE . Differing effects of methylenetetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis. Pharmacogenetics 2002; 12: 181\u2013182.","journal-title":"Pharmacogenetics"},{"key":"BFleu2008323_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/ard.58.2.79","volume":"58","author":"CJ Haagsma","year":"1999","unstructured":"Haagsma CJ, Blom HJ, van Riel PL, van\u2019t Hof MA, Giesendorf BA, Oppenraaij-Emmerzaal D et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58: 79\u201384.","journal-title":"Ann Rheum Dis"},{"key":"BFleu2008323_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00277-006-0184-3","volume":"86","author":"I Kim","year":"2007","unstructured":"Kim I, Lee KH, Kim JH, Ra EK, Yoon SS, Hong YC et al. Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Ann Hematol 2007; 86: 41\u201348.","journal-title":"Ann Hematol"},{"key":"BFleu2008323_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bmt.1705330","volume":"37","author":"K Robien","year":"2006","unstructured":"Robien K, Schubert MM, Chay T, Bigler J, Storb R, Yasui Y et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 37: 799\u2013800.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2008323_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.bmt.1705319","volume":"37","author":"N Murphy","year":"2006","unstructured":"Murphy N, Diviney M, Szer J, Bardy P, Grigg A, Hoyt R et al. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate. Bone Marrow Transplant 2006; 37: 773\u2013779.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2008323_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.bbmt.2006.05.016","volume":"12","author":"K Robien","year":"2006","unstructured":"Robien K, Bigler J, Yasui Y, Potter JD, Martin P, Storb R et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 2006; 12: 973\u2013980.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2008323_CR51","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","volume":"95","author":"GR Hill","year":"2000","unstructured":"Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754\u20132759.","journal-title":"Blood"},{"key":"BFleu2008323_CR52","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.1158\/1078-0432.CCR-04-1057","volume":"10","author":"K Robien","year":"2004","unstructured":"Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B et al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004; 10: 7592\u20137598.","journal-title":"Clin Cancer Res"},{"key":"BFleu2008323_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/367284a0","volume":"367","author":"NA Morrison","year":"1994","unstructured":"Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284\u2013287.","journal-title":"Nature"},{"key":"BFleu2008323_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gene.2004.05.014","volume":"338","author":"AG Uitterlinden","year":"2004","unstructured":"Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP . Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143\u2013156.","journal-title":"Gene"},{"key":"BFleu2008323_CR55","first-page":"277","volume":"49","author":"CE Hayes","year":"2003","unstructured":"Hayes CE, Nashold FE, Spach KM, Pedersen LB . The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy -le-grand) 2003; 49: 277\u2013300.","journal-title":"Cell Mol Biol (Noisy -le-grand)"},{"key":"BFleu2008323_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.bmt.1702873","volume":"27","author":"I Pakkala","year":"2001","unstructured":"Pakkala I, Taskinen E, Pakkala S, Raisanen-Sokolowski A . MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation. Bone Marrow Transplant 2001; 27: 863\u2013867.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2008323_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.bmt.1703629","volume":"30","author":"PG Middleton","year":"2002","unstructured":"Middleton PG, Cullup H, Dickinson AM, Norden J, Jackson GH, Taylor PR et al. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 223\u2013228.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2008323_CR58","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1073\/pnas.121172198","volume":"98","author":"MD Griffin","year":"2001","unstructured":"Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R . Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 6800\u20136805.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2008323_CR59","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/abbi.1999.1605","volume":"374","author":"CM Veldman","year":"2000","unstructured":"Veldman CM, Cantorna MT, Deluca HF . Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374: 334\u2013338.","journal-title":"Arch Biochem Biophys"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2008323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008323","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2008323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:24:22Z","timestamp":1648729462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2008323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,13]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFleu2008323"],"URL":"https:\/\/doi.org\/10.1038\/leu.2008.323","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,13]]},"assertion":[{"value":"5 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}